HOME › DRUGS › ADUCANUMAB
ACTIVE SUBSTANCE / INN

ADUCANUMAB

Brand name(s): Aduhelm
EMA LISTED
APPLICATION WITHDRAWN
Alzheimer Disease
ACTIVE SUBSTANCE
Aducanumab
REGULATORS
EMA
SPONSORS / MAH
Biogen Netherlands B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AduhelmBiogen Netherlands B.V.Application withdrawnAlzheimer Disease

FULL INTELLIGENCE ON ADUCANUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →